Grand Challenges at the Interface of Engineering and Medicine

Shankar Subramaniam, Metin Akay, Mark A. Anastasio, Vasudev J. Bailey, David A. Boas, Paolo Bonato, Ashutosh Chilkoti, Jennifer R. Cochran, Vicki L. Colvin, Tejal A. Desai, James S. Duncan, Frederick H. Epstein, Stephanie I. Fraley, Cecilia M. Giachelli, K. Jane Grande‐Allen, Jordan J. Green, X. Edward Guo, Isaac B. Hilton, Jay D. Humphrey, Chris R. Johnson, George Em Karniadakis, Michael R. King, Robert F. Kirsch, Sanjay Kumar, Cato T. Laurencin, Song Li, Richard L. Lieber, Nigel H. Lovell, Prashant Mali, Susan S. Margulies, David F. Meaney, Brenda M. Ogle, Bernhard Ø. Palsson, Nicholas A. Peppas, Eric J. Perreault, Richard D. Rabbitt, Lori A. Setton, Lonnie D. Shea, Sanjeev G. Shroff, Kirk Shung, Andreas S. Tolias, Marjolein C. H. van der Meulen, Shyni Varghese, Gordana Vunjak‐Novakovic, John A. White, Raimond L. Winslow, Jianyi Zhang, Kun Zhang, Charles F. Zukoski, Michael I. MillerIEEE Open Journal of Engineering in Medicine and Biology 2024 · DOI

Abstract

Over the past two decades, Biomedical Engineering (BME) has emerged as a major discipline bridging societal healthcare needs with novel technology development. We are now at the nexus of creating "avatars"—extensions of digital twins—of human physiology to serve as paradigms for interrogation and intervention. This paper, a result of an interdisciplinary workshop sponsored by the IEEE EMBS, Johns Hopkins University, and UC San Diego, identifies five grand challenges: 1) AccuMedicine through avatars; 2) smart and responsive devices for human augmentation; 3) exocortical technologies for brain function; 4) harnessing the immune system; and 5) engineering genomes and cells.

Introduction: From Reactive to Proactive Healthcare

Despite the explosion of biological data from genomics and advanced imaging, modern healthcare remains largely reactive and generalized. While we can monitor human health at unprecedented scales, the field lacks integrated models to translate this "multiscale myriad" of data into precise, actionable outcomes for individual patients.

The authors propose a unified vision for BME, arguing that the discipline must move beyond tool-building to lead the creation of a new "engineering basis of human physiology." This shift toward "AccuMedicine" requires solving massive technical hurdles in data integration, real-time sensing, and therapeutic delivery.

Overview of the five Grand Challenges at the interface of engineering and medicine and their enabling technologies.

The Five Grand Challenges

1. Precision Medicine and Human Avatars

The concept of a human "avatar" goes beyond a standard digital twin. It includes both in-silico models and physical, ex vivo surrogates, such as patient-specific organ-on-a-chip systems. These avatars allow clinicians to test interventions on a physical manifestation of the patient before applying them to the body, integrating genomic, transcriptomic, and lifestyle data for real-time feedback.

2. The Smart Human: Augmenting Function

This challenge focuses on developing permanent, responsive systems—such as artificial lungs or prosthetic limbs—that sense their environment and adapt in real-time. The goal is to ensure homeostasis and augment human function through smart, autonomous devices.

3. The ExoBrain: Engineering the Mind

The "ExoBrain" represents an external processing layer interfacing with the biological brain. This involves mapping the brain across ten orders of magnitude (from synapses to whole-brain imaging) and developing non-invasive neuroaugmentation technologies to treat neurodegeneration and mirror brain function externally.

4. Immuno-Engineering: The Immune Toolbox

Rather than simply "boosting" the immune system, the goal is to create a "toolbox" to quantify and program immune cell phenotypes with mechanical precision. This includes engineering next-generation vaccines and therapies that can establish immunological tolerance for autoimmune diseases.

5. Engineering Life: The Genome as Software

DNA is framed as "hardware" and epigenetic regulation as the "operating system." Mastering "Engineering Life" requires moving from reading the code to controlling the OS. A primary bottleneck is the "delivery challenge"—creating safe, tissue-targeted systems that can edit the genome in vivo.

Strategic Roadmap and Enabling Technologies

The roadmap was developed by synthesizing expert perspectives on societal needs, technical hurdles, and enabling technologies. Key enablers include:

  • Multimodal Sensing: Developing sensors for dynamic feedback of the "digital human."
  • Data Science & AI: Bridging the gap between nanoscale molecular data and whole-body outcomes.
  • Advanced Materials: Utilizing cell manufacturing and material science for tissue fabrication and microphysiological platforms.

Limitations and Future Outlook

The transition to this engineering-driven future faces several hurdles:

  • The Delivery Bottleneck: Getting therapeutic payloads to specific cells without toxicity remains a major challenge for gene and cell therapies.
  • Model Poverty: The field is currently "data rich but model poor." Computational challenges in bridging scales are significant.
  • Education and Ethics: BME education must evolve to include ethics, data science, and clinical medicine as core pillars to avoid working in silos.
  • Regulatory Evolution: Moving from animal models to human surrogates (like organ-on-a-chip) for drug approval requires a difficult but necessary regulatory transition.

By addressing these challenges, the 21st century will see engineering and medicine become indistinguishable, ushering in an era of proactive, personalized health maintenance.

Summary updated

Abstract

Over the past two decades Biomedical Engineering has emerged as a major discipline that bridges societal needs of human health care with the development of novel technologies. Every medical institution is now equipped at varying degrees of sophistication with the ability to monitor human health in both non-invasive and invasive modes. The multiple scales at which human physiology can be interrogated provide a profound perspective on health and disease. We are at the nexus of creating "avatars" (herein defined as an extension of "digital twins") of human patho/physiology to serve as paradigms for interrogation and potential intervention. Motivated by the emergence of these new capabilities, the IEEE Engineering in Medicine and Biology Society, the Departments of Biomedical Engineering at Johns Hopkins University and Bioengineering at University of California at San Diego sponsored an interdisciplinary workshop to define the grand challenges that face biomedical engineering and the mechanisms to address these challenges. The Workshop identified five grand challenges with cross-cutting themes and provided a roadmap for new technologies, identified new training needs, and defined the types of interdisciplinary teams needed for addressing these challenges. The themes presented in this paper include: 1) accumedicine through creation of avatars of cells, tissues, organs and whole human; 2) development of smart and responsive devices for human function augmentation; 3) exocortical technologies to understand brain function and treat neuropathologies; 4) the development of approaches to harness the human immune system for health and wellness; and 5) new strategies to engineer genomes and cells.
BibTeX
@article{subramaniam2024grand,
  author = {Shankar Subramaniam and Metin Akay and Mark A. Anastasio and Vasudev J. Bailey and David A. Boas and Paolo Bonato and Ashutosh Chilkoti and Jennifer R. Cochran and Vicki L. Colvin and Tejal A. Desai and James S. Duncan and Frederick H. Epstein and Stephanie I. Fraley and Cecilia M. Giachelli and K. Jane Grande‐Allen and Jordan J. Green and X. Edward Guo and Isaac B. Hilton and Jay D. Humphrey and Chris R. Johnson and George Em Karniadakis and Michael R. King and Robert F. Kirsch and Sanjay Kumar and Cato T. Laurencin and Song Li and Richard L. Lieber and Nigel H. Lovell and Prashant Mali and Susan S. Margulies and David F. Meaney and Brenda M. Ogle and Bernhard Ø. Palsson and Nicholas A. Peppas and Eric J. Perreault and Richard D. Rabbitt and Lori A. Setton and Lonnie D. Shea and Sanjeev G. Shroff and Kirk Shung and Andreas S. Tolias and Marjolein C. H. van der Meulen and Shyni Varghese and Gordana Vunjak‐Novakovic and John A. White and Raimond L. Winslow and Jianyi Zhang and Kun Zhang and Charles F. Zukoski and Michael I. Miller},
  title = {{Grand Challenges at the Interface of Engineering and Medicine}},
  journal = {IEEE Open Journal of Engineering in Medicine and Biology},
  year = {2024},
  doi = {10.1109/ojemb.2024.3351717},
}
Figure